Gapping up
In reaction to earnings/guidance:
- TITN +10.6%, WOOF +10%, XPEV +9.8%, WDAY +9.2% (also authorizes new $500 mln share repurchase program), BEKE +7.9%, DOOO +3.9%, CMP +3.6%, HPE +1.8%, ENB +1.6%, DCI +1.4%, NAT +1.4%, FRO +0.7%
Other news:
- HZNP +33.1% (confirms preliminary discussions regarding potential buyout)
- VRDN +15.8% (in sympathy with HZNP M&A news)
- LUNG +9.2% (announces that the Japanese Ministry of Health Labour and Welfare has approved the Zephyr Endobronchial Valve for treating severe COPD/emphysema patients following a positive recommendation by Pharmaceuticals and Medical Devices Agency)
- W +6.8% (reports post-Thanksgiving sales)
- CBL +3% (declares special dividend of $2.20/sh)
- MAXR +3% (to build two new geostationary communications satellites for SiriusXM)
- BIIB +2.9% (Biogen and Eisai presents full results of Lecanemab Phase 3 confirmatory clarity ad study for early Alzheimer's disease at Clinical Trials on Alzheimer's Disease conference)
- WBX +2.4% (private placement of $43.5 mln)
- SANA +2.3% (confirms key program timelines and portfolio prioritization)
- NOTV +1.8% (to close two isolator facilities)
- BRY +1.6% (provides management succession plan; Fernando Araujo to become CEO)
- PBI +1.4% (discusses business strategy)
- BA +1.3% (awarded $398 mln U.S. Air Force modification contract)
- BLUE +1.2% (sells Priority Review Voucher for $102 mln)
- RIO +1% (provides update to progress strategy to strengthen decarbonise and grow)
- CRM +1% (U.S. online sales rose 9% yr/yr during Cyber week)
Analyst comments:
- SOUN +5.3% (upgraded to Overweight from Neutral at Cantor Fitzgerald)